How have ACXP and ENLV total returns compared?

Over the past 5 years, ACXP delivered -57.41% and ENLV delivered -69.81% annualized total return. Past performance doesn't predict future results.

Acurx Pharmaceuticals, Inc. (ACXP) vs Enlivex Therapeutics Ltd. (ENLV)

A side-by-side comparison of Acurx Pharmaceuticals, Inc. and Enlivex Therapeutics Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ACXP

Acurx Pharmaceuticals, Inc.

$6M

$1.31HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT

ENLV

Enlivex Therapeutics Ltd.

$6M

$0.35HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT

Total return — ACXP vs ENLV

growth of $100 · dividends reinvested · last 5y

ACXP -99.2% (-61.6%/yr)ENLV -99.7% (-69.6%/yr)ACXP compounded faster over this window

ACXP ENLV

ACXP vs ENLV: by the numbers

•ENLV is the larger company ($6M vs $6M market cap).

Metrics side by side

Valuation

Metric	ACXP	ENLV
P/E ratio	N/A	0.00
P/B ratio	0.69	0.00

Profitability

Metric	ACXP	ENLV
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	0.00%	0.00%
ROE	-92.08%	105.35%
ROIC	-94.08%	-0.32%

Growth (annualized)

Metric	ACXP	ENLV
Total return CAGR (5Y)	-57.41%	-69.81%

Frequently asked

How have ACXP and ENLV total returns compared?: Over the past 5 years, ACXP delivered -57.41% and ENLV delivered -69.81% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ACXP analysis Full ENLV analysis Interactive comparison tool

Dig into the metrics

Acurx Pharmaceuticals ROE Enlivex Therapeutics ROE Acurx Pharmaceuticals operating margin Enlivex Therapeutics operating margin Acurx Pharmaceuticals revenue growth Enlivex Therapeutics revenue growth Acurx Pharmaceuticals free cash flow Enlivex Therapeutics free cash flow

Acurx Pharmaceuticals & Enlivex Therapeutics appear in these rankings

Highest ROE Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.